Servier acquires non-Hodgkin B-cell lymphoma treatment PIXUVRI (pixantrone) from CTI BioPharma Read more
Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir Read more
Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing Read more
Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Malignant Ascites Read more
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal Read more
Exclusive Bionical EMAS speaker interview released for the Orphan Drugs & Rare Diseases Conference Read more